Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has the Geriatric Medicines Market Growth Performance Trended Historically, And What Lies Ahead?

Recent years have witnessed a swift expansion in the market size of geriatric medicines. The market will surge from a value of $1227.91 billion in 2024 up to a staggering $1430.84 billion in 2025, registering a compound annual growth rate (CAGR) of 16.5%. Factors contributing to this substantial growth during the historic period include the growing incidence of stroke, a surge in the prevalence of chronic ailments, a rise in cardiovascular disease cases, augmented government support, and a heightened focus on personalized medicine.

The market size for geriatric medicines is predicted to witness significant expansion in the forthcoming years. By 2029, the market is projected to reach a value of $2604.86 billion, growing at a compound annual growth rate (CAGR) of 16.2%. The anticipated growth during the forecast period is associated with factors such as an increasing occurrence of health conditions connected with ageing, escalating geriatric populace, increasing healthcare costs, the surge in the field of geriatric medicine, and a rise in the cases of hypertension. The forecast period is also likely to see key trends including the adoption of digital tablets and wearable healthcare gadgets, the establishment of strategies and tools for safe multiple medication management, advancements in gene and stem cell therapies, wider implementation of telehealth services, and progress in early detection and prevention of diseases related to ageing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20817&type=smp

Which Factors and External Forces Are Driving Demand in the Geriatric Medicines Market?

The rise in age-related health issues is anticipated to stimulate the geriatric medicines market’s growth. As a result of the aging process, these health concerns intensify and become more common with age. The escalating prevalence of these health conditions is primarily fueled by longer life spans, advancements in medical care, and an aging population. Geriatric medicines, which offer specialized care for the elderly, aid in managing these age-related health issues, thus enhancing their quality of life and health outcomes. For example, a report by the UK’s Office for Health Improvement and Disparities (OHID) indicated that 17.6% of individuals aged 16 and up had a long-term musculoskeletal (MSK) condition, like arthritis or persistent back or joint problems, which is an increase from the 17.0% reported in 2021. Consequently, the growing prevalence of age-related health issues propels the growth of the geriatric medicines market.

Which Segments in the Geriatric Medicines Offer the Most Growth?

The geriatric medicines market covered in this report is segmented –

1) By Therapeutics: Analgesics, Antihypertensive, Statins, Proton Pump Inhibitors, Anticoagulant, Antipsychotic, Other Therapeutics

2) By Condition: Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory, Other Conditions

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Analgesics: Non-Opioid Analgesics (Acetaminophen, NSAIDs), Opioid Analgesics (Morphine, Oxycodone), Topical Analgesics (Lidocaine Patches)

2) By Antihypertensive: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Beta-Blockers, Calcium Channel Blockers, Diuretics, Alpha-Blockers

3) By Statins: Atorvastatin, Simvastatin, Rosuvastatin, Pravastatin, Lovastatin

4) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole

5) By Anticoagulant: Warfarin, Direct Oral Anticoagulants (DOACs): Dabigatran, Rivaroxaban, Apixaban, Heparin

6) By Antipsychotic: Atypical Antipsychotics, Typical Antipsychotics

7) By Other Therapeutics: Antidepressants (SSRIs, SNRIs), Antidiabetic Medications (Insulin, Metformin), Anticonvulsants, Anti-Inflammatory Drugs (Corticosteroids), Cognitive Enhancers (Donepezil, Memantine)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20817&type=smp

What Are the Fastest-Growing Geographies in the Geriatric Medicines Market?

North America was the largest region in the geriatric medicines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geriatric medicines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Geriatric Medicines Industry?

Leading firms in the geriatric medicines market are aiming to innovate revolutionary diabetes treatments to meet the surging demand for efficient remedies among the elderly population. The therapies are specifically designed to boost diabetes management or offer feasible cures beyond the conventional methods, ensuring improved safety, efficacy, and patient results. For example, in August 2023, Akums Drugs & Pharmaceuticals Ltd., an organization based in India, which specializes in contract manufacturing pharmaceuticals, introduced a new combination therapy that includes Vildagliptin SR and Metformin SR. This modern formulation is specifically designed to tackle the issue of Type 2 diabetes in older patients. The therapy aims to maintain effective blood sugar control while minimizing common issues like hypoglycemia and weight gain, which are especially important for the older population. By strategically combining the functionalities of both these drugs, the therapy augments insulin production and successfully lowers blood sugar, thus ensuring its safety and efficacy. The Drug Controller General of India (DCGI) has granted regulatory approval for the product.

View the full report here:

https://www.thebusinessresearchcompany.com/report/geriatric-medicines-global-market-report

What Are the Key Elements That Define the Geriatric Medicines Market?

Geriatric medicines are medications prescribed for individuals aged 65 and older, addressing the unique health needs of the elderly. They are designed to support cognitive function, mobility, and immune health while considering the physiological changes that affect drug metabolism in older adults. These medications manage chronic conditions and age-related symptoms, enhancing overall quality of life.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20817

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model